Announced details
Procurement, manufacturing, storage, transportation and last-mile delivery of pharmaceuticals, medical devices and materials, diagnostic reagents, nutrition products, OTC products and other healthcare products, as well as medical facilities and home care
コラボクリエイト will establish a joint venture structure with the six companies listed above and enter into a business alliance with SoftBank Corp. Each partner company will dispatch a part-time director and a dedicated representative. Each partner company is expected to invest in コラボクリエイト, but the equity stakes have not been disclosed.
MITSUI-SOKO HOLDINGS Co.,Ltd. is the holding company of an integrated logistics group engaged in warehousing, port transportation and international transportation. SEINO HOLDINGS CO.,LTD. operates primarily in transportation through a group of 101 companies with approximately 34,000 employees. TOHO HOLDINGS CO.,LTD. is engaged in pharmaceutical wholesaling, dispensing pharmacies, pharmaceutical manufacturing and sales, and customer-support systems. OHKI HEALTHCARE HOLDINGS CO.,LTD. oversees a wholesale business focused on OTC products. 株式会社八神製作所 is a specialized medical-device trading company and a member of セイエイ・エル・サンテホールディング株式会社. 宮野医療器株式会社 is a specialized trading company for medical and scientific equipment. SoftBank Corp. provides telecommunications services and various solutions. No information is provided on the location or capital of any of the companies.
14F MSH Nihombashi-Hakozaki Building, 19-21 Nihombashi-Hakozaki-cho, Chuo-ku, Tokyo
Not disclosed
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Healthcare logistics business addressing social issues, Contract logistics services for pharmaceutical manufacturers, Integrated proposals and contract logistics services for healthcare products, including medical devices and materials, diagnostic reagents, nutrition products and OTC products |
| Counterparty | MITSUI-SOKO HOLDINGS Co.,Ltd., SEINO HOLDINGS CO.,LTD., TOHO HOLDINGS CO.,LTD., OHKI HEALTHCARE HOLDINGS CO.,LTD., 株式会社八神製作所（セイエイ・エル・サンテホールディング株式会社）, 宮野医療器株式会社, SoftBank Corp. |
| Counterparty overview | MITSUI-SOKO HOLDINGS Co.,Ltd. is the holding company of an integrated logistics group engaged in warehousing, port transportation and international transportation. SEINO HOLDINGS CO.,LTD. operates primarily in transportation through a group of 101 companies with approximately 34,000 employees. TOHO HOLDINGS CO.,LTD. is engaged in pharmaceutical wholesaling, dispensing pharmacies, pharmaceutical manufacturing and sales, and customer-support systems. OHKI HEALTHCARE HOLDINGS CO.,LTD. oversees a wholesale business focused on OTC products. 株式会社八神製作所 is a specialized medical-device trading company and a member of セイエイ・エル・サンテホールディング株式会社. 宮野医療器株式会社 is a specialized trading company for medical and scientific equipment. SoftBank Corp. provides telecommunications services and various solutions. No information is provided on the location or capital of any of the companies. |
| Relationship with the Company | コラボクリエイト will establish a joint venture structure with the six companies listed above and enter into a business alliance with SoftBank Corp. Each partner company will dispatch a part-time director and a dedicated representative. Each partner company is expected to invest in コラボクリエイト, but the equity stakes have not been disclosed. |
| Contract Date | 25 March 2026 (resolved at the meeting of the Board of Directors held today) |
| Launch date | コラボクリエイト is scheduled to be established on 1 April 2026. Investment by each partner company is scheduled for late May 2026. |
| Applicable area | Procurement, manufacturing, storage, transportation and last-mile delivery of pharmaceuticals, medical devices and materials, diagnostic reagents, nutrition products, OTC products and other healthcare products, as well as medical facilities and home care |
| Location | 14F MSH Nihombashi-Hakozaki Building, 19-21 Nihombashi-Hakozaki-cho, Chuo-ku, Tokyo |
| Location scale | 15 employees at establishment and approximately 30 after the capital increase (planned) |
| Impact on Business Performance | Not disclosed |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To combine the assets, capabilities and expertise of the respective companies to implement solutions to challenges including the declining birthrate and aging population, the expansion of home-based and community healthcare, shortages of personnel, regional disparities, constrained transportation capacity due to the 2024 logistics issue, compliance with quality-control requirements for pharmaceuticals and medical devices, stable supply, business continuity planning (BCP), and reducing environmental impact.